Rising Prevalence of Cardiovascular Diseases
Cardiovascular diseases are the leading cause of deaths across the globe. The burden of cardiovascular disease is estimated to be around 29% of the total deaths around the world. According to the American Heart Association by 2030, 40.5% of the U.S. population is expected to suffer from cardiovascular disease. It is estimated that the total direct cost of cardiovascular diseases from 2010 to 2030 would be almost three times from US$ 273 Bn to US$ 818 Bn. This factor is expected to drive the growth of the global angio suites market.
Government Funding and Support for Development of New Innovative Medical Devices
Growing incidence of life-threatening diseases has majorly resulted in rise in the number of diagnostics procedures worldwide. It is estimated that the direct and indirect costs of diagnosis and imaging will increase over a period of time. To develop cost-effective and efficient medical devices, various governments in developed countries are actively funding R&D activities.
For instance, the New South Wales (NSW), a state government from Australia, has availed medical devices fund of about US$ 8 million in 2017–2018 to help encourage and support investments in the development and commercialization of medical devices and related technologies.
Lack of Skilled Professionals and Standard Usage Guidelines
The lack of skilled healthcare professionals for operating angio suites within the healthcare domain represents a prime obstacle in the growth of the angio suites market in emerging economies. Presently, the demand for skilled employees is rising, especially in the Middle East and Africa, due to the limited availability of resources. A fundamental requirement to work on cardiac devices should be trained, skilled cardiac specialists and professionals within the healthcare domain for day to day operations and maintenance.
Globally, the demand is increasing for diagnostic procedures however, due to the limited number of skilled operators and professionals, growth of the market is expected to be stagnant. The improper implementation and development of clinical practice guidelines in most of the counties are factors hindering the growth of the market. Furthermore, the lack of a proper regulatory framework is also expected to restrain the growth of the global angio suites market.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Lack of Proper Healthcare Infrastructure in Emerging Markets
Presently, many regions, e.g., Russia, lack adequate operation infrastructure, which is essential to conduct test, surgeries and technology implementation compared to the U.S. and other developed countries. These economies lack the widespread access to surgical procedures, which may hamper the growth of the global angio suites market. Moreover, the high cost involved in the initial set up and installation of advanced angio suites and broadband technology in remote locations could also hamper the growth of the angio suites market.
This section of the report features profiles of key players operating in the angio suites market based on their market share, market structure, product offerings, differential strategies, company dashboard and marketing approach. Examples of some of the key players featured in this report include GE Healthcare, Koninklijke Philips N.V., Siemens AG, Shimadzu Corporation, Canon, Inc., and others. Emerging players operating in the angio suites market are majorly focusing on new marketing strategies in order to expand their product footprint in the global angio suites market.
Angio suites offer most advanced imaging capabilities with improved spatial resolution. Some of the services offered in angio suites are aortic dissection, abdominal aortic aneurysm, carotid artery disease, complex peripheral artery disease, traumatic aortic injury, and others. Angio suites provide both diagnostic and interventional care to reduce and eliminate the pain.
About the Report
The report offers a comprehensive evaluation of the business opportunities in the angio suites market along with insights on the consumer adoption process, competition blueprint, list of key distributors and suppliers for the duration from 2018 to 2028.
Additional Questions Answered
Some of the additional questions addressed in this report on angio suites market-
- What is the revenue potential across regions of North America and Europe?
- Who are the key competitors in the market and what are their portfolios?
- What are the major challenges influencing the growth of the angio suites market?
- How is intervention from regulatory authorities shaping the market growth?
The angio suites market has been projected based on install base approach. The angio suites market was first calculated based on an average number of angio suites installed in different region/countries. The install base of angio suites was estimated based on the installation of equipment’s in hospitals, and cath labs globally. Furthermore, others qualitative factors studied during angio suites market estimation include average lifespan, the percentage of new sales of angio suites, the actual replacement rate of angio suites, and others.
This information is further validated with primary research (including surveys, interviews, in-person interactions, and viewpoints of surgeons) and secondary research (including authentic trade journals, verified paid sources, and resourceful databases).
The research study on angio suites market also includes top trends and macroeconomic factors shaping the angio suites market. With this approach, the report on angio suites market assumes the industry attractiveness of every key segment over the forecast period.
The report offers a comprehensive taxonomy of the angio suites market on the basis of product type, end user and region. On the basis of product type, the global angio suites market has been segmented into biplane angio suites and single plane angio suites.
On the basis of end user, the global angio suites market has been segmented into hospitals and cath labs. From a geographical perspective, the angio suites market has been segmented into North America, Latin America, Europe, Asia Pacific and Middle East & Africa (MEA).